Researchers are exploring Manfredokimab AK120, a innovative interleukin 17A (IL-17A) blocker , for a treatment approach for patients with ulcerative colitis. Preliminary data demonstrate that this therapy https://socialmediainuk.com/story27213370/manfredokimab-ak120-a-promising-possibility-for-uc